Skip to content

Activating Collaborative CIS Support Via Targeted Provider Mailing

Activating Collaborative CIS Support Via Targeted Provider Mailing

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00873288
Enrollment
254
Registered
2009-04-01
Start date
2006-10-31
Completion date
2008-11-30
Last updated
2023-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Precancerous Condition

Keywords

cervical intraepithelial neoplasia, atypical squamous cells of undetermined significance, high-grade squamous intraepithelial lesion, low-grade squamous intraepithelial lesion

Brief summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Detailed description

OBJECTIVES: * Compare the effect of a usual care mailing intervention vs a Cancer Information Service (CIS) support mailing intervention on the likelihood that women with an abnormal Pap test will keep their medical follow-up appointments and be satisfied with how they talk to their provider. OUTLINE: This is a multicenter study. Patients are randomized to 1 of 2 intervention arms. * Arm I (Usual-care mailing intervention): Patients receive a generic letter reminding them of their follow-up colposcopy appointment. * Arm II (Cancer Information Service \[CIS\] support mailing intervention): Patients receive a targeted letter reminding them of their follow-up colposcopy appointment, asking them or someone they designate to call the CIS, and suggesting some questions to ask the CIS about colposcopies and Pap tests. At their follow-up appointments, all patients undergo an exit interview to compare patient satisfaction between the 2 interventions. Patients in arm II also answer questions about their CIS experience, and if the intervention made their follow-up visit less difficult.

Interventions

OTHERUsual care mailing intervention

routine colposcopy reminder letter

OTHERCIS support mailing intervention

Mailed reminder plus provider recommendation to call CIS and sample questions to ask

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Northwestern University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

DISEASE CHARACTERISTICS: * Received an abnormal Pap test result * Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic PATIENT CHARACTERISTICS: * Female * Able to communicate in either English or Spanish * Clinic staff will review patient charts to determine eligibility PRIOR CONCURRENT THERAPY: * Not specified

Exclusion criteria

* \<18 years * unable to communicate in English or Spanish * no address to which a letter can be mailed

Design outcomes

Primary

MeasureTime frameDescription
Patient Satisfaction in the 2 Interventionswithin 6 months of PAPPatient satisfaction with provider-patient communication was assessed via administration of the Consumer Assessment of Health Plans Study (CAHPS) satisfaction questionnaire which rates satisfaction on a 1 to 3 scale. Scores are added together, with minimum score being 4 and the maximum score being 12, with a higher score indicating greater satisfaction.
CIS Experience of Patients in Arm II and the Effect of the Intervention on Their Follow-up Colposcopywithin 6 months of PAP

Secondary

MeasureTime frame
Attendance at a Follow-up Colposcopy Appointment Within 6 Months of Their Pap Testwithin 6 months of PAP
Latency Between the Pap Test and the Colposcopy Appointmentwithin 6 months of PAP
Number of CIS Callers Who Provided the Specific Codes Listed in the Intervention LetterWITHIN 6 MONTHS OF PAP

Countries

United States

Participant flow

Participants by arm

ArmCount
Usual Care Mailing Intervention
routine colposcopy reminder letter mailed
127
CIS Support Mailing Intervention
Mailed reminder plus provider recommendation to call CIS and sample questions to ask
127
Total254

Baseline characteristics

CharacteristicCIS Support Mailing InterventionUsual Care Mailing InterventionTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
127 Participants127 Participants254 Participants
Age, Continuous27.8 years
STANDARD_DEVIATION 9.3
28.1 years
STANDARD_DEVIATION 9.1
27.95 years
STANDARD_DEVIATION 9.2
Region of Enrollment
United States
127 participants127 participants254 participants
Sex: Female, Male
Female
127 Participants127 Participants254 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 1270 / 127
serious
Total, serious adverse events
0 / 1270 / 127

Outcome results

Primary

CIS Experience of Patients in Arm II and the Effect of the Intervention on Their Follow-up Colposcopy

Time frame: within 6 months of PAP

Population: The apparatus that Boeing built to identify which CIS callers were from the study did not function correctly. Therefore, we could not determine whether participants called CIS or not.

Primary

Patient Satisfaction in the 2 Interventions

Patient satisfaction with provider-patient communication was assessed via administration of the Consumer Assessment of Health Plans Study (CAHPS) satisfaction questionnaire which rates satisfaction on a 1 to 3 scale. Scores are added together, with minimum score being 4 and the maximum score being 12, with a higher score indicating greater satisfaction.

Time frame: within 6 months of PAP

ArmMeasureValue (MEAN)Dispersion
Usual Care Mailing InterventionPatient Satisfaction in the 2 Interventions11.79 score on a scaleStandard Deviation 0.563
CIS Support Mailing InterventionPatient Satisfaction in the 2 Interventions11.68 score on a scaleStandard Deviation 0.912
p-value: >0.05t-test, 2 sided
Secondary

Attendance at a Follow-up Colposcopy Appointment Within 6 Months of Their Pap Test

Time frame: within 6 months of PAP

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual Care Mailing InterventionAttendance at a Follow-up Colposcopy Appointment Within 6 Months of Their Pap Test107 Participants
CIS Support Mailing InterventionAttendance at a Follow-up Colposcopy Appointment Within 6 Months of Their Pap Test102 Participants
p-value: 0.207Chi-squared
Secondary

Latency Between the Pap Test and the Colposcopy Appointment

Time frame: within 6 months of PAP

ArmMeasureValue (MEAN)
Usual Care Mailing InterventionLatency Between the Pap Test and the Colposcopy Appointment39.5 days
CIS Support Mailing InterventionLatency Between the Pap Test and the Colposcopy Appointment42.5 days
p-value: 0.66t-test, 2 sided
Secondary

Number of CIS Callers Who Provided the Specific Codes Listed in the Intervention Letter

Time frame: WITHIN 6 MONTHS OF PAP

Population: The apparatus that Boeing built to identify which CIS callers were from the study did not function correctly. Therefore, we could not determine whether participants called CIS or not.

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026